Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Authors
Keywords
-
Journal
CANCER INVESTIGATION
Volume 32, Issue 7, Pages 349-362
Publisher
Informa UK Limited
Online
2014-06-06
DOI
10.3109/07357907.2014.919301
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
- (2013) Annie Im et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI
- (2013) E. A. Copelan et al. BLOOD
- Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation
- (2013) C. Bredeson et al. BLOOD
- Optimizing Outcomes Following Allogeneic Hematopoietic Progenitor Cell Transplantation in AML: The Role of Hypomethylating Agents
- (2013) Massimo Martino et al. CURRENT CANCER DRUG TARGETS
- CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
- (2013) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study
- (2012) J. E. Levine et al. BLOOD
- Chronic GVHD: Where are we? Where do we want to be? Will immunomodulatory drugs help?
- (2012) Y P L Linhares et al. BONE MARROW TRANSPLANTATION
- Diagnosis and management of chronic graft-versus-host disease
- (2012) Fiona L. Dignan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease
- (2012) Ran Reshef et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
- (2012) Claudio Anasetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Single-Nucleotide Polymorphism–Based Risk Model for Clinical Outcomes After Allogeneic Stem-Cell Transplantation, Especially for Acute Graft-Versus-Host Disease
- (2012) Dennis (Dong Hwan) Kim et al. TRANSPLANTATION
- Higher Busulfan Dose Intensity Does Not Improve Outcomes of Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (AHCT) Following Fludarabine/Busulfan/Atg (FBA)-Based Reduced Toxicity Conditioning (RTC)
- (2011) M. Hamadani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The Incidence of Veno-Occlusive Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Has Diminished and the Outcome Improved over the Last Decade
- (2011) Enric Carreras et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- {inverted question}Como se LLAMA?
- (2011) J. S. Bennett BLOOD
- Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease
- (2011) J. L. M. Ferrara et al. BLOOD
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
- (2011) M. E. D. Flowers et al. BLOOD
- Novel treatment concepts for graft-versus-host disease
- (2011) D. Wolf et al. BLOOD
- Risk factors for acute GVHD and survival after hematopoietic cell transplantation
- (2011) M. Jagasia et al. BLOOD
- Acute graft-versus-host disease following hematopoietic stem-cell transplantation
- (2011) STEPHANIE W. HU et al. Dermatologic Therapy
- Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendations
- (2011) Kai Hübel et al. LEUKEMIA & LYMPHOMA
- Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update
- (2011) B Mohty et al. Blood Cancer Journal
- High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
- (2010) L. Luznik et al. BLOOD
- Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning
- (2010) N. S. Majhail et al. BLOOD
- The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure
- (2010) S. Spellman et al. BLOOD
- Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia
- (2010) J P Uberti et al. BONE MARROW TRANSPLANTATION
- Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis
- (2010) N. Kroger et al. HAEMATOLOGICA
- Allogeneic stem cell transplantation for acute myeloid leukemia
- (2010) J. Peccatori et al. HAEMATOLOGICA
- High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation
- (2010) Leo Luznik et al. IMMUNOLOGIC RESEARCH
- Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
- (2010) Joseph Pidala et al. Journal of Hematology & Oncology
- Allogeneic hematopoietic cell transplantation: the state of the art
- (2010) Boglarka Gyurkocza et al. Expert Review of Hematology
- Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation
- (2009) Seth M. Pollack et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Many faces of graft-versus-host disease
- (2009) Pablo F Peñas et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia
- (2009) Elias Jabbour et al. CANCER
- The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2009) Seok Lee et al. CANCER
- Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update
- (2009) Holbrook Kohrt et al. CURRENT OPINION IN HEMATOLOGY
- Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
- (2009) Jürgen Finke et al. LANCET ONCOLOGY
- Solid cancers after allogeneic hematopoietic cell transplantation
- (2008) J. D. Rizzo et al. BLOOD
- Outside-in: peptide versus integrin
- (2008) J. S. Bennett BLOOD
- Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation
- (2008) C. Cutler et al. BLOOD
- A biomarker panel for acute graft-versus-host disease
- (2008) S. Paczesny et al. BLOOD
- Prophylaxis regimens for GVHD: systematic review and meta-analysis
- (2008) R Ram et al. BONE MARROW TRANSPLANTATION
- Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen–Identical Sibling Transplants for Adults With Leukemia
- (2008) Theresa Hahn et al. JOURNAL OF CLINICAL ONCOLOGY
- Recognizing and Managing Chronic Graft-Versus-Host Disease
- (2008) S. J. Lee et al. Hematology-American Society of Hematology Education Program
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now